Amundi’s Fate Therapeutics FATE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-4,990
Closed -$15.3K 2167
2024
Q3
$15.3K Hold
4,990
﹤0.01% 1917
2024
Q2
$15.8K Buy
+4,990
New +$21.8K ﹤0.01% 1860
2023
Q4
Sell
-7,154
Closed -$12.2K 2025
2023
Q3
$12.2K Hold
7,154
﹤0.01% 1965
2023
Q2
$34.5K Hold
7,154
﹤0.01% 1927
2023
Q1
$39.3K Sell
7,154
-4,664
-39% -$28.1K ﹤0.01% 1909
2022
Q4
$67.6K Sell
11,818
-70,030
-86% -$1.32M ﹤0.01% 1657
2022
Q3
$1.93M Sell
81,848
-153,845
-65% -$4.45M ﹤0.01% 1157
2022
Q2
$7.43M Sell
235,693
-121,846
-34% -$3.36M 0.01% 839
2022
Q1
$14.1M Sell
357,539
-23,595
-6% -$914K 0.01% 738
2021
Q4
$16.1M Sell
381,134
-18,520
-5% -$1.05M 0.01% 732
2021
Q3
$23.7M Sell
399,654
-8,833
-2% -$693K 0.02% 648
2021
Q2
$35.5M Buy
+408,487
New +$32.9M 0.02% 525

Other funds holding FATE